REFERENCES
- Wilson WR, Karchmer AW, Dajani A et al. Antibiotic treatment of adults with infective endocarditis due to strepto-cocci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274: 1706–1713.
- Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 1979; 16 686-689.
- Cercenado E, Eliopoulos GM, Wennersten CB, Moellering RCJr. Influence of high-level gentamicin resis-tance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin. Antimicrob Agents Chemother 1992; 36: 2526–2528.
- Chow JW, Donabedian SM, Clewell DB, Sahm DF, Zervos MJ. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci. Diagn Microbiol Infect Dis 1998; 32: 141–6.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, PA, 1997.
- National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. Document M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1987.
- National Committee for Clinical Laboratory Standards. Methodology for the serum bactericidal test. Document M-21A. National Committee for Clinical Laboratory Standards, Villanova, PA. 1999.
- Ravizzola G, Cabibbo E, Peroni L et al. In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococchi. J Antimicrob Chemother 1997; 39: 461–70.